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This data article contains full list of autophagy related genes that are
altered in diabetic heart. This article also shows data from in vitro
cultured cardiomyocytes that are exposed the high glucose treat-
ment to simulate hyperglycemic state in vitro. The interpretation of
these data and further extensive insights into the regulation of SG
biogenesis by AMPK can be found in “Type-2 diabetes increases
autophagy in the human heart through promotion of Beclin-1
mediated pathway” (Munasinghe et al., in press) [1].
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article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations tableubject area Cardiovascularvier Inc. This is an open access article under the CC BY license
/j.ijcard.2015.08.111
atare).
m, Nottingham, UK.
kayama, Japan.
MT
H
D
E
E
D
P.E. Munasinghe et al. / Data in Brief 5 (2015) 269–275270ore speciﬁc sub-
ject areaDiabetic heart diseaseype of data RT-proﬁler array and in vitro data
ow data was
acquiredRT proﬁler array uses speciﬁc software to do the calculations. in vitro data
analysis was done using GraphPad Prism software.ata format Analyzed
xperimental
factorsN/Axperimental
featuresN/Aata source location Department of Physiology-HeartOtago, Dunedin, New Zealand and Bristol
Heart Institute, Bristol, United Kingdomata accessibility Data within this articleD1. Value of the data First RT proﬁler array data for autophagy genes in the diabetic heart.
 In addition to beclin-1, RT proﬁler analysis of diabetic heart identiﬁed marked changes in several
other genes. This could provide a benchmark for future research studies determining the patho-
physiological role of other genes in autophagy.
 Isolated adult cardiomyocytes could be a valuable source to study the effect of diabetes in vitro.2. Data, experimental design, materials and methods
2.1. Data
RT proﬁler array showed marked activation of several autophagy related genes with beclin-1 being
markedly increased compared to other genes (Table 1). Importantly, exposure of adult cardiomyo-
cytes to high glucose markedly increased the level of beclin-1 within 24 h with a peak increase at 48 h
(Fig. 1A). Importantly, the caspase activation which indicates cell death followed the beclin-1 acti-
vation (Fig. 1B).3. Experimental design, materials and methods
3.1. Animal model of type-2 diabetes
Male obese leptin-receptor mutant BKS.Cg-þLeprdb/þLeprdb/OlaHsd mice (Harlan, UK) were used
as a model of insulin-resistant type-2 DM. Elevations of blood glucose begin at four to six weeks in
these mutant mice. Age matched lean mice (BKS.Cg-mþ/þLeprdb/OlaHsd) were used as control.
These mice best represent the human model of type-2 diabetes [2,3].
3.2. RNA extraction and RT-proﬁler array for autophagy genes
Total RNA was extracted from the left ventricle of 8-weeks old diabetic and non-diabetic lean mice
using Trizol, according to the manufacturer's instructions (Invitrogen, UK). After conﬁrming the purity
and integrity of the total RNA, cDNAwas prepared from 1 mg of total RNA by Transcription Kit (Qiagen,
UK). The activation of apoptotic genes was then evaluated using murine RT-proﬁler PCR autophagy
array (Qiagen, UK) using a light cycler (Roche 480, UK). Data were analyzed using the software
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signiﬁcant [1,4,5].
3.3. Isolation and culture of adult cardiomyocytes
3.3.1. Isolation and culture of rat adult cardiomyocytes
The male Wistar rats were killed by cervical dislocation, the heart dissected and rinsed in cold
solution A containing (in mM): 137 NaCl, 5 KCl, 1.2 MgSO4, 1.2 NaH2PO4, 20 N-hydro-
xyethylpiperazine-N0-2-ethanesulphonic acid (HEPES), 16 glucose, 5 Na pyruvate and 1.8 MgCl2 (pH
7.25 with NaOH)þ0.75 mM CaCl2. The heart was cannulated via the aorta and perfused for 4 min with
solution Aþ0.75 mM CaCl2 (all perfusing solutions were oxygenated and maintained at 37 °C). This
was followed by a 4-min perfusion with solution Aþ0.09 mM ethylene glycol-bis (β-aminoethyl
ether) N,N,N,N0-tetraacetic acid (EGTA). Next the heart was digested with 50 ml of enzyme solutionTable 1
RT proﬁler assay showing changes in the expression pattern of autophagy associated genes in the type-2 diabetic mouse heart
at 12 weeks of age. Activation of the autophagy genes was evaluated using murine RT-proﬁler PCR autophagy array (Qiagen,
UK). RNA from snap frozen mouse hearts (12 weeks of age) was isolated with TRIzol (Invitrogen, UK). One microgram of total
RNA was reverse transcribed and resulting cDNA was ampliﬁed in a light cycler (Roche 480, UK). Data were analyzed using the
software package from Qiagen and expressed as fold-changes to non-diabetic. Genes showing a fold change of Z2 and a T-test
of o0.05 were considered to be signiﬁcantly modulated.
Table 1 (continued )
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Table 1 (continued )
Highlighted in green are the signiﬁcantly modulated autophagy related genes and highlighted in yellow are the signiﬁcantly
modulated cell survival related genes. Genes which are statistically signiﬁcant (irrespective of the fold changes) are highlighted
in red.
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Lakewood, New Jersey, USA. Type I), 5 mg protease (Sigma, Poole, Dorset, UK. Type IV), with (gluta-
mate loaded) or without (control) 6.4 mM potassium L-glutamate until the tissue felt soft. There was
a ﬁnal 4-min perfusion with solution Aþ0.15 mM CaCl2 before the ventricles were cut down and
sliced. The sliced ventricles were suspended in approximately 20–25 ml solution Aþ0.15 mM CaCl2
and shaken for 6 min at 37 °C. After ﬁltration, cells were allowed to sediment, the supernatant was
discarded, and the remaining cell layer suspended in solution Aþ0.5 mM CaCl2. This sedimentation,
removal of supernatant and resuspension step was repeated, but this time the cells were suspended
in solution Aþ1 mM CaCl2. This technique typically produced a yield of over 90% rod-shaped cells
with the ability to exclude Trypan Blue [6]. The resulting cells were then washed separately with
medium 199 (Invitrogen) supplemented with 0.2% BSA, 10% FBS, 5 mM creatine, 5 mM taurine, 2 mM
carnitine, 10 mM cytosine-D-arabinofuranoside (all from Sigma chemicals), ITS and antibiotics (both
from Invitrogen). After the ﬁnal wash cells were resuspended in the same medium and plated on
laminin coated culture dish according to the experiments [2].
Fig. 1. A. Representative blots and bar graphs showing the level of Beclin-1 in rat cardiomyocytes exposed to high glucose
(30 mM). B. Bar graphs showing Caspase-3/7 activity in normal and high glucose treated cardiomyocytes at different time
points. NG – normal glucose; HG – high glucose. Values are mean7SD of 4 independent experiments and are expressed as fold
changes to cells treated with NG at corresponding time point. **Po0.01 and ***Po0.001 vs. NG treated cells at corresponding
time point.
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After isolation 1106 cardiomyocytes were seeded on a laminin coated T25 ﬂask and allowed to
settle for 4 h. After 4 h cardiomyocytes were exposed to high glucose (HG, 30 mM) or Mannitol (NG,
30 mM for osmotic control) to simulate diabetic condition in vitro for 48 h. After 48 h, the effect of HG
treatment on beclin-1 was measured by western blotting [7] and cell survival by caspase-3/7 activity
as described earlier [2,8].Acknowledgments
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